Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology

NCT02822404 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Kidney Diseases

Interventions

DIETARY_SUPPLEMENT: Urinary and blood sample for Cystatine dosage

Sponsor

University Hospital, Toulouse